ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Latest Updates of Viva Biotech's Portfolio Companies PRNewswire
January 08, 2025Recently, Viva Biotech's portfolio companies have new updates: TechnoDerma, VivaVision, Arthrosi, Apeiron Therapeutics and AceLink made solid progress in R&D; Full Circles published breakthrough results; Antag successfully completed financing. -
APEIRON Biologics’ APN01 Selected for US COVID-19 Trail americanpharmaceuticalreview
May 20, 2021APEIRON Biologics, a private European biotech company, announced next steps for APN01 (alunacedase alfa) for COVID-19 treatment. -
APEIRON Appoints CMSO
contractpharma
August 29, 2018APEIRON Biologics AG?has appointed Anderson Gaweco, M.D., Ph.D. as its chief medical and scientific officer (CMSO).
Pharma Sources Insight January 2025
